Skeletal muscle ceramides do not contribute to physical-inactivity-induced insulin resistance

Appl Physiol Nutr Metab. 2019 Nov;44(11):1180-1188. doi: 10.1139/apnm-2018-0850. Epub 2019 Mar 19.

Abstract

Physical inactivity increases the risk to develop type 2 diabetes, a disease characterized by a state of insulin resistance. By promoting inflammatory state, ceramides are especially recognized to alter insulin sensitivity in skeletal muscle. The present study was designed to analyze, in mice, whether muscle ceramides contribute to physical-inactivity-induced insulin resistance. For this purpose, we used the wheel lock model to induce a sudden reduction of physical activity, in combination with myriocin treatment, an inhibitor of de novo ceramide synthesis. Mice were assigned to 3 experimental groups: voluntary wheel access group (Active), a wheel lock group (Inactive), and wheel lock group treated with myriocin (Inactive-Myr). We observed that 10 days of physical inactivity induces hyperinsulinemia and increases basal insulin resistance (HOMA-IR). The muscle ceramide content was not modified by physical inactivity and myriocin. Thus, muscle ceramides do not play a role in physical-inactivity-induced insulin resistance. In skeletal muscle, insulin-stimulated protein kinase B phosphorylation and inflammatory pathway were not affected by physical inactivity, whereas a reduction of glucose transporter type 4 content was observed. Based on these results, physical-inactivity-induced insulin resistance seems related to a reduction in glucose transporter type 4 content rather than defects in insulin signaling. We observed in inactive mice that myriocin treatment improves glucose tolerance, insulin-stimulated protein kinase B, adenosine-monophosphate-activated protein kinase activation, and glucose transporter type 4 content in skeletal muscle. Such effects occur regardless of changes in muscle ceramide content. These findings open promising research perspectives to identify new mechanisms of action for myriocin on insulin sensitivity and glucose metabolism.

Keywords: AMP kinase; Akt; HOMA-IR; NF-κB; triglycerides; triglycérides.

MeSH terms

  • Adenylate Kinase / metabolism
  • Animals
  • Ceramides / analysis*
  • Fatty Acids, Monounsaturated / pharmacology
  • Glucose Tolerance Test
  • Glucose Transporter Type 4 / metabolism
  • Insulin Resistance*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal / chemistry*
  • Phosphorylation
  • Physical Conditioning, Animal
  • Proto-Oncogene Proteins c-akt / metabolism
  • Sedentary Behavior*
  • Sphingolipids / analysis
  • Triglycerides / analysis

Substances

  • Ceramides
  • Fatty Acids, Monounsaturated
  • Glucose Transporter Type 4
  • Slc2a4 protein, mouse
  • Sphingolipids
  • Triglycerides
  • Proto-Oncogene Proteins c-akt
  • Adenylate Kinase
  • thermozymocidin